---
title: "Alternative Therapy For Bladder Cancer"
url: https://alsuprun.com/blog/alternative-therapy/alternative-therapy-for-bladder-cancer-2/
author: "Editorial"
date: 2026-09-09T19:07:46+00:00
categories: ["alternative therapy"]
tags: []
---

# Alternative Therapy For Bladder Cancer

Conventional treatments for bladder cancer typically involve surgery, chemotherapy and radiation therapies; at UT MD Anderson’s Urologic Department our urologists offer advanced surgical and reconstruction techniques – such as robotic-assisted surgeries – as part of their comprehensive care.

 Trimodality therapy combines intravesical therapy, targeted medicines and immunotherapy in order to effectively treat bladder cancer patients. By doing so, it lowers their risk of recurrence and progression and can reduce recurrence rates as well as progression rates.

 

## Intravesical Bacillus Calmette-Guerin (BCG) Therapy

 BCG treatment is an intravesical immunotherapy – meaning a liquid drug that’s administered via catheter to activate immune system cells that target abnormal bladder cancer cells and eliminate them. BCG is typically reserved for early stage nonmuscle-invasive bladder cancer which still exists close to or on the inner lining. BCG stands out as one of the most successful examples of microbial therapy used against cancer to date.

 [![Rejuvenate your whole body & balance your health without medications - now remotely!](https://alsuprun.com/blog/wp-content/uploads/BioresonanceTopAd.png)](https://www.bioresonance.rent) The BCG vaccine contains Mycobacterium bovis bacteria similar to those responsible for tuberculosis; however, its effect is usually milder in most people and therefore weakened to limit any harm done to your body by exposure.

 Scientists have long understood that BCG could help prevent and treat nonmuscle-invasive bladder cancer, but its exact mechanisms were unknown until recently. One theory suggested it works by infecting bladder tumors so your immune cells can attack them directly.

 BCG may have another beneficial effect: altering the programming of stem cells and early-stage blood cells found in your bone marrow so they’re better at fighting tumors – an intriguing and innovative strategy for treating or preventing bladder cancer.

 [![](https://alsuprun.com/blog/wp-content/uploads/ForeverYoungYouWannaBe.png)](https://alsuprun.com/services.html#Contact) Researchers have created recombinant BCG strains expressing proteins to increase their ability to adhere and be internalized by urothelial cells, such as one strain expressing fimH (mannose-binding protein). Such an improvement was noted both with respect to adhesion as well as in some instances increased antitumor responses.

 Scientists have recently discovered that recombinant BCG strains expressing IL-15 can recruit neutrophils to the bladder following instillation, leading to clinical trials evaluating BCG/IL-15 immunotherapy treatments as part of combination treatments.

 Recent research indicates that patients with NMIBC who completed all courses of BCG experienced increased overall survival, cancer-specific survival and recurrence-free survival compared to those who didn’t finish all treatments. Though BCG supplies may have decreased since its availability has become limited, it remains essential that NMIBC patients continue with their treatments.

 

## Systemic Therapy

 Bladder cancer is the sixth-most prevalent malignancy in the US. Most bladder tumors are superficial; however, 30% penetrate past the bladder submucosa/mucosa and into its muscle layer – classified as muscle-invasive bladder cancer or MIBC. Patients diagnosed with muscle-invasive cancer face an increased risk of distant metastases that could potentially prove lethal.

 Most advanced bladder cancer, both MIBC and metastatic disease, is usually best addressed using systemic therapy – drugs that circulate throughout the body to reach cancer cells – combined with local treatments like surgery or radiation.

 Chemotherapy is the foundation of systemic treatment for bladder cancer, with numerous regimens including those using cisplatin-based combination therapies having the best documented outcomes. Neoadjuvant chemotherapy with these agents greatly improved survival for MIBC as did radiotherapy; for unresectable or metastatic tumors chemotherapy remains the cornerstone treatment option and newer immunotherapies such as immunotherapy may prove more successful;

 [![](https://alsuprun.com/blog/wp-content/uploads/RadionicMerch.png)](https://alsuprun.com/merch.html) BCAN supports clinical trials that evaluate promising new treatments prior to becoming widely available, as well as traditional ones. You can gain more information and find out how you can participate by visiting BCAN’s Bladder Cancer Trials Database.

 Some patients may benefit from undergoing bladder preservation, which involves extracting only the portion of bladder that contains cancer while leaving the rest of their urinary tract unaltered. While this approach can reduce recurrence risks and preserve bladder function, it may not be suitable for everyone.

 Urologists can provide guidance regarding the risks and advantages associated with this option.

 Palliative care aims to relieve any associated discomfort during and post treatment, from pain management to symptoms relief. Your physician will work with you to create an individualized plan tailored specifically for you; for instance, some individuals may benefit from BCG injections combined with local treatments while others find relief through an entirely oral regimen. Palliative care services may start immediately and continue through all aspects of care for as long as needed.

 

## Chemotherapy

 Cancer-fighting drugs can enter your body through various methods. They can enter via an intravenous line (intravesical chemotherapy), directly into the bladder (intravesical chemotherapy), the abdomen (intraperitoneal chemotherapy), or your chest cavity (intrathecal chemotherapy). Or they could even be given intravenously into your bloodstream (intravenous chemotherapy).

 Immunotherapy helps the immune system detect and eliminate tumor cells more effectively. A type called checkpoint inhibitor blocks a protein on cancer cell surfaces so your own immune system can recognize them more readily – for instance pembrolizumab (Keytruda).

 Muscle-invasive bladder cancer can spread beyond its original boundaries and into surrounding tissues, making treatment more challenging than earlier-stage cancers. Surgery is often recommended to reduce the risk of the cancer returning; depending on your specific circumstances, surgery might involve having all or part of your bladder removed (radical cystectomy) while other therapies may reduce chances that new cancers form or return.

 After having your bladder surgically removed, chemotherapy can help eradicate any cancer cells remaining. Intravenous chemotherapy is usually given through a vein; however, medicines can also be delivered directly into your bladder via catheterization or to areas in your belly where cancer was located (intraperitoneal and intrathecal chemotherapy).

 Immunotherapeutic options provide additional help to your immune system as it battles cancer more effectively, both alone and when used alongside BCG therapy. Some of these therapies have even become standard of care in cancer care regimens.

 One promising treatment option is an extract of Somalian Frankincense herb Boswellia carteri, which has been proven to kill bladder cancer cells in laboratory studies. Curcumin, another natural substance taken as a supplement or added directly to food, has also been shown to block cancer cell growth while helping shield against its side effects while simultaneously reducing inflammation and improving absorption of medications prescribed to you by your doctor.

 

## Radiation

 As soon as someone is diagnosed with bladder cancer, they often must make many difficult choices about treatment plans that include surgery and medicine – as well as what to do if their cancer recurs or spreads.

 Recent years have witnessed an exponentially-increasing variety of options for treating bladder cancer. Unfortunately, severe side effects and the development of resistance impede long-term success – leading many patients to seek nonconventional, alternative, or complementary therapies as a supplement to conventional therapies.

 Curcumin has been proven to possess cancer-preventive properties. Clinical and preclinical research have confirmed this fact; studies conducted both before and after chemotherapy treatments showed an increase in efficacy while decreasing side effects, thus protecting organs from damage.

 Intravesical gene therapy (IVGT) can also be an effective solution for both invasive and non-invasive bladder cancer, and involves inserting a tube into the bladder that delivers copies of a gene directly into cells – telling them to produce interferon, which aids the body against cancer. BCG and IVGT treatment has both been found effective against recurrences while it has also been studied alongside other cancer medicines.

 Additional treatments that may be employed to address invasive bladder cancer include multiple doses of intravenous chemotherapy, radiation, and immunotherapy. These therapies may be given along with BCG or after it, or they can even be given for those whose cancer returns post surgery.

 Radical cystectomy refers to surgical removal of an entire bladder. It may be advised for people who are either ineligible for traditional surgery or their cancer keeps coming back despite BCG and other treatments, as this option might require finding another means of urination such as using ureal conduits or creating an alternative neobladder from part of the intestine as their only options for relief.

 Research efforts are also ongoing to discover new immunotherapeutic treatments for both invasive and non-invasive bladder tumors, with some promising findings so far. For instance, one such drug, known as Nodaragene Firadenovec (Adstiladrine), is being evaluated as a therapy against BCG-unresponsive papillary bladder cancer; targeting its cell signaling pathway that promotes its growth it has had a successful response rate in early trials with high response rates, showing promise in terms of improving outcomes and patient health care outcomes.

```json
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Alternative Therapy For Bladder Cancer",
    "url": "https://alsuprun.com/blog/alternative-therapy/alternative-therapy-for-bladder-cancer-2/",
    "datePublished": "2026-09-09T19:07:46+00:00",
    "dateModified": "2026-09-09T19:07:55+00:00",
    "author": {
        "@type": "Person",
        "name": "Editorial"
    },
    "publisher": {
        "@type": "Organization",
        "name": "Information Wellness Blog",
        "url": "https://alsuprun.com/blog/"
    }
}
```